Article

Walking Speed May Predict MS Disease Progression

T25FW among factors linked to disease worsening


 

References

Several factors associated with worsening in timed 25-foot walk (T25FW) scores and other clinical indicators may be used to predict clinically significant change in patients with multiple sclerosis, according to an analysis of 1,544 patients.

Investigators reviewed patients who experienced a 20% or greater worsening in T25FW, and found the following factors related to disease progression:

• lower baseline Multiple Sclerosis Performance Scales (MSPS) scores

• sex, baseline T25FW, and time since diagnosis

• Patient Health Questionaire-9 (PHQ9) scores

The disease course time to worsening was significantly shorter for secondary progressive compared to relapsing-remitting disease.

Citation: Miller DM, Thompson NR, Cohen JA, et al. Factors associated with clinically significant increased walking time in multiple sclerosis: results of a survival analysis of short-term follow-up data from a clinical database. Mult Scler. 2015;21(4):457-465. doi: 10.1177/1352458514544536.

Recommended Reading

Urinary Tract Symptoms in MS
MDedge Neurology
Wellness Programs May Improve Quality of Life
MDedge Neurology
Menopause Exacerbates Multiple Sclerosis Symptoms
MDedge Neurology
Using the Story Memory Technique in Multiple Sclerosis
MDedge Neurology
Improving Memory in Multiple Sclerosis
MDedge Neurology
DMT may reduce disability-worsening events in multiple sclerosis
MDedge Neurology
Interferon beta, glatiramer acetate prove effective for relapsing MS
MDedge Neurology
Biomarker sCD27 indicates intrathecal inflammation
MDedge Neurology
Patients With MS Have Lower Levels of Key Nutrients
MDedge Neurology
FDA approves first generic version of MS drug glatiramer acetate
MDedge Neurology